Cargando…

A Novel Role for the Interleukin-1 Receptor Axis in Resistance to Anti-EGFR Therapy

Cetuximab (CTX) is a monoclonal antibody targeting the epidermal growth factor receptor (EGFR), commonly used to treat patients with metastatic colorectal cancer (mCRC). Unfortunately, objective remissions occur only in a minority of patients and are of short duration, with a population of cells sur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gelfo, Valerio, Mazzeschi, Martina, Grilli, Giada, Lindzen, Moshit, Santi, Spartaco, D’Uva, Gabriele, Győrffy, Balázs, Ardizzoni, Andrea, Yarden, Yosef, Lauriola, Mattia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6210663/ https://www.ncbi.nlm.nih.gov/pubmed/30261609 http://dx.doi.org/10.3390/cancers10100355

Ejemplares similares

A module of inflammatory cytokines defines resistance of colorectal cancer to EGFR inhibitors
por: Gelfo, Valerio, et al.
Publicado: (2016)

Senescence-associated reprogramming induced by interleukin-1 impairs response to EGFR neutralization
por: Romaniello, Donatella, et al.
Publicado: (2022)

Glucocorticoid Receptor Modulates EGFR Feedback upon Acquisition of Resistance to Monoclonal Antibodies
por: Gelfo, Valerio, et al.
Publicado: (2019)

The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in consensus molecular subtype 1 colon cancer
por: Mazzeschi, Martina, et al.
Publicado: (2022)

Aberrant MET activation impairs perinuclear actin cap organization with YAP1 cytosolic relocation
por: Sgarzi, Michela, et al.
Publicado: (2023)

IL-1 and senescence: Friends and foe of EGFR neutralization and immunotherapy
por: Romaniello, Donatella, et al.
Publicado: (2023)

Diurnal suppression of EGFR signalling by glucocorticoids and implications for tumour progression and treatment
por: Lauriola, Mattia, et al.
Publicado: (2014)

Roles of IL-1 in Cancer: From Tumor Progression to Resistance to Targeted Therapies
por: Gelfo, Valerio, et al.
Publicado: (2020)

Extracellular Vesicles and Epidermal Growth Factor Receptor Activation: Interplay of Drivers in Cancer Progression
por: Ferlizza, Enea, et al.
Publicado: (2023)

L858R emerges as a potential biomarker predicting response of lung cancer models to anti-EGFR antibodies: Comparison of osimertinib vs. cetuximab
por: Marrocco, Ilaria, et al.
Publicado: (2023)

A recombinant decoy comprising EGFR and ErbB-4 inhibits tumor growth and metastasis
por: Lindzen, Moshit, et al.
Publicado: (2011)

Upfront admixing antibodies and EGFR inhibitors preempts sequential treatments in lung cancer models
por: Marrocco, Ilaria, et al.
Publicado: (2021)

Neuregulin 4 Boosts the Efficacy of Anti-ERBB2 Neutralizing Antibodies
por: Miano, Carmen, et al.
Publicado: (2022)

Trapping all ERBB ligands decreases pancreatic lesions in a murine model of pancreatic ductal adenocarcinoma
por: Hedegger, Kathrin, et al.
Publicado: (2023)

Beta-Catenin/HuR Post-Transcriptional Machinery Governs Cancer Stem Cell Features in Response to Hypoxia
por: D’Uva, Gabriele, et al.
Publicado: (2013)

Polyclonal antibody-induced downregulation of HER1/EGFR and HER2 surpasses the effect of combinations of specific registered antibodies
por: Bergado-Báez, Gretchen, et al.
Publicado: (2022)

Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms and Strategies for Cardioprotection
por: Morelli, Marco Bruno, et al.
Publicado: (2022)

A new method for the study of biophysical and morphological parameters in 3D cell cultures: Evaluation in LoVo spheroids treated with crizotinib
por: Sargenti, Azzurra, et al.
Publicado: (2021)

NRG1/ERBB3/ERBB2 Axis Triggers Anchorage-Independent Growth of Basal-like/Triple-Negative Breast Cancer Cells
por: Miano, Carmen, et al.
Publicado: (2022)

An oligoclonal antibody durably overcomes resistance of lung cancer to third‐generation EGFR inhibitors
por: Mancini, Maicol, et al.
Publicado: (2017)

Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone
por: Enuka, Yehoshua, et al.
Publicado: (2017)

Targeting HER3, a Catalytically Defective Receptor Tyrosine Kinase, Prevents Resistance of Lung Cancer to a Third-Generation EGFR Kinase Inhibitor
por: Romaniello, Donatella, et al.
Publicado: (2020)

AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer
por: Noronha, Ashish, et al.
Publicado: (2022)

Epigenetic control of the basal-like gene expression profile via Interleukin-6 in breast cancer cells
por: D'Anello, Laura, et al.
Publicado: (2010)

PD-L1 recruits phospholipase C and enhances tumorigenicity of lung tumors harboring mutant forms of EGFR
por: Ghosh, Soma, et al.
Publicado: (2021)

Adenomatous Polyposis Coli (APC) regulates miR17-92 cluster through β-catenin pathway in colorectal cancer
por: Li, Yajuan, et al.
Publicado: (2016)

EGFR in Cancer: Signaling Mechanisms, Drugs, and Acquired Resistance
por: Uribe, Mary Luz, et al.
Publicado: (2021)

Resistance of Lung Cancer to EGFR-Specific Kinase Inhibitors: Activation of Bypass Pathways and Endogenous Mutators
por: Marrocco, Ilaria, et al.
Publicado: (2023)

Circular RNAs are long-lived and display only minimal early alterations in response to a growth factor
por: Enuka, Yehoshua, et al.
Publicado: (2016)

Targeting autocrine amphiregulin robustly and reproducibly inhibits ovarian cancer in a syngeneic model: roles for wildtype p53
por: Lindzen, Moshit, et al.
Publicado: (2021)

Targeting the Interplay of Independent Cellular Pathways and Immunity: A Challenge in Cancer Immunotherapy
por: Lauriola, Angela, et al.
Publicado: (2023)

The EGFR-HER2 module: a stem cell approach to understanding a prime target and driver of solid tumors
por: Schneider, Marlon R., et al.
Publicado: (2015)

Emerging Novel Therapeutic Approaches for Treatment of Advanced Cutaneous Melanoma
por: Comito, Francesca, et al.
Publicado: (2022)

Can Reporting Heterogeneity Explain Differences in Depressive Symptoms Across Europe?
por: Kok, Renske, et al.
Publicado: (2011)

Recurrent Pregnancy Loss and Thrombophilia
por: D’Uva, Maristella, et al.
Publicado: (2010)

Venous thromboembolism and pregnancy
por: D’Uva, Maristella, et al.
Publicado: (2010)

Reawakening the Intrinsic Cardiac Regenerative Potential: Molecular Strategies to Boost Dedifferentiation and Proliferation of Endogenous Cardiomyocytes
por: Bongiovanni, Chiara, et al.
Publicado: (2021)

The importance of assessing the self-reported impact of COVID-19 on clinician mental health
por: Kapila, A.K., et al.
Publicado: (2020)

Drug-induced colitis on BRAF and MEK inhibitors for BRAF V600E-mutated non-small cell lung cancer: a case report
por: Gelsomino, Francesco, et al.
Publicado: (2021)

Hop derived flavonoid xanthohumol inhibits endothelial cell functions via AMPK activation
por: Gallo, Cristina, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ji1efo8suq1bjgfgm5aipgdbe0